Cryoport (CYRX) News Today $6.16 +0.07 (+1.15%) Closing price 04/2/2025 04:00 PM EasternExtended Trading$5.92 -0.24 (-3.83%) As of 04/2/2025 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Cryoport price target raised to $11 from $10 at UBSApril 2 at 11:45 AM | markets.businessinsider.comCryoPort (CYRX) Gets a Buy from Roth MKMApril 2 at 11:45 AM | markets.businessinsider.comUBS Group Forecasts Strong Price Appreciation for Cryoport (NASDAQ:CYRX) StockUBS Group boosted their price target on Cryoport from $10.00 to $11.00 and gave the company a "buy" rating in a research note on Tuesday.April 2 at 11:04 AM | marketbeat.comCryoport's (CYRX) "Buy" Rating Reiterated at Roth MkmApril 2 at 2:51 AM | americanbankingnews.comCryoport (NASDAQ:CYRX) Earns "Buy" Rating from Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and issued a $11.00 price target on shares of Cryoport in a report on Monday.April 1 at 12:51 PM | marketbeat.comDHL Group acquires Cryopdp from Cryoport, terms not disclosedMarch 31 at 9:07 PM | markets.businessinsider.com4CYRX : Expert Outlook: CryoPort Through The Eyes Of 4 AnalystsMarch 31 at 9:07 PM | benzinga.comCryoport, Inc. (CYRX) Strategic Agreement and Transaction with DHL Group Call (Transcript)March 31 at 4:09 PM | seekingalpha.comBiggest stock movers Monday: COOP, HSMT, CYRX, PCVX, MRNA, NNOX and moreMarch 31 at 4:07 PM | msn.comDHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"March 31 at 9:06 AM | prnewswire.comCryoport to Host Investor Call to Discuss Recent Strategic Agreement and Transformative Transaction Today, March 31, 2025, at 8:30 a.m. ETMarch 31 at 8:09 AM | prnewswire.comOkabena Investment Services Inc. Purchases Shares of 79,072 Cryoport, Inc. (NASDAQ:CYRX)Okabena Investment Services Inc. acquired a new position in shares of Cryoport, Inc. (NASDAQ:CYRX - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 79,072 shares of the company's stock, valued at approximately $61March 30, 2025 | marketbeat.comCryoport price target lowered to $10 from $11 at GuggenheimMarch 29, 2025 | markets.businessinsider.comCryoport, Inc. (NASDAQ:CYRX) CEO Jerrell Shelton Sells 2,980 SharesCryoport, Inc. (NASDAQ:CYRX - Get Free Report) CEO Jerrell Shelton sold 2,980 shares of Cryoport stock in a transaction that occurred on Monday, March 24th. The shares were sold at an average price of $6.94, for a total transaction of $20,681.20. Following the sale, the chief executive officer now owns 762,419 shares of the company's stock, valued at approximately $5,291,187.86. The trade was a 0.39 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.March 27, 2025 | marketbeat.comCryoport, Inc. (NASDAQ:CYRX) CEO Jerrell Shelton Sells 2,980 Shares of StockMarch 27, 2025 | insidertrades.comA Deep Look At Cryoport's Dead Cat BounceMarch 26, 2025 | seekingalpha.comUBS Group Upgrades Cryoport (NASDAQ:CYRX) to BuyMarch 26, 2025 | americanbankingnews.comCryoport (NASDAQ:CYRX) Upgraded to "Buy" at UBS GroupUBS Group upgraded Cryoport from a "neutral" rating to a "buy" rating and set a $10.00 price objective for the company in a research report on Monday.March 25, 2025 | marketbeat.comPerkins Capital Management Inc. Grows Stock Holdings in Cryoport, Inc. (NASDAQ:CYRX)Perkins Capital Management Inc. increased its stake in Cryoport, Inc. (NASDAQ:CYRX - Free Report) by 1,286.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 159,400 shares of the company's stock after purchasing an additioMarch 25, 2025 | marketbeat.comCryoport upgraded to Buy from Neutral at UBSMarch 25, 2025 | markets.businessinsider.comUBS Upgrades Cryoport (CYRX)March 24, 2025 | msn.comInsider Selling: Cryoport, Inc. (NASDAQ:CYRX) CFO Sells 1,659 Shares of StockCryoport, Inc. (NASDAQ:CYRX - Get Free Report) CFO Robert Stefanovich sold 1,659 shares of the firm's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $6.29, for a total transaction of $10,435.11. Following the completion of the transaction, the chief financial officer now directly owns 191,419 shares in the company, valued at $1,204,025.51. This represents a 0.86 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.March 19, 2025 | marketbeat.comInsider Selling: Cryoport, Inc. (NASDAQ:CYRX) CEO Sells 4,620 Shares of StockCryoport, Inc. (NASDAQ:CYRX - Get Free Report) CEO Jerrell Shelton sold 4,620 shares of the business's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $6.29, for a total transaction of $29,059.80. Following the sale, the chief executive officer now owns 765,399 shares of the company's stock, valued at $4,814,359.71. This trade represents a 0.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.March 19, 2025 | marketbeat.comCryoport, Inc. (NASDAQ:CYRX) CFO Robert Stefanovich Sells 1,659 SharesMarch 19, 2025 | insidertrades.comIs Cryoport, Inc. (CYRX) a Pump and Dump Stock Favored by Hedge Funds?March 18, 2025 | insidermonkey.comIs Cryoport, Inc. (CYRX) a Pump and Dump Stock Favored by Hedge Funds?March 18, 2025 | msn.comCryoPort (CYRX) Surges 5.9%: Is This an Indication of Further Gains?March 13, 2025 | msn.comCryoport, Inc. (NASDAQ:CYRX) Receives Average Rating of "Moderate Buy" from AnalystsShares of Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) have earned an average rating of "Moderate Buy" from the six research firms that are presently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold rating and four have issued a buy rating on the comMarch 13, 2025 | marketbeat.comCryoport, Inc. (NASDAQ:CYRX) CEO Sells $20,364.24 in StockCryoport, Inc. (NASDAQ:CYRX - Get Free Report) CEO Jerrell Shelton sold 4,173 shares of Cryoport stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $4.88, for a total value of $20,364.24. Following the transaction, the chief executive officer now directly owns 740,019 shares of the company's stock, valued at $3,611,292.72. The trade was a 0.56 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.March 12, 2025 | marketbeat.comCryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical LaboratoriesMarch 12, 2025 | prnewswire.comCryoport, Inc. (NASDAQ:CYRX) CEO Jerrell Shelton Sells 4,173 SharesMarch 12, 2025 | insidertrades.comResearch Analysts Set Expectations for Cryoport Q1 EarningsCryoport, Inc. (NASDAQ:CYRX - Free Report) - Roth Capital cut their Q1 2025 earnings per share (EPS) estimates for Cryoport in a research note issued to investors on Wednesday, March 5th. Roth Capital analyst R. Baldry now forecasts that the company will post earnings of ($0.34) per share for theMarch 8, 2025 | marketbeat.comFY2026 Earnings Estimate for Cryoport Issued By Roth CapitalCryoport, Inc. (NASDAQ:CYRX - Free Report) - Equities researchers at Roth Capital issued their FY2026 EPS estimates for shares of Cryoport in a research note issued to investors on Wednesday, March 5th. Roth Capital analyst R. Baldry forecasts that the company will earn ($1.23) per share for theMarch 7, 2025 | marketbeat.comCryoport, Inc.: Cryoport Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 6, 2025 | finanznachrichten.deCryoPort trading halted, volatility trading pauseMarch 6, 2025 | markets.businessinsider.comCryoport, Inc. (NASDAQ:CYRX) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | msn.comCryoport (NASDAQ:CYRX) Announces Quarterly Earnings Results, Misses Expectations By $0.09 EPSCryoport (NASDAQ:CYRX - Get Free Report) issued its earnings results on Tuesday. The company reported ($0.42) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.33) by ($0.09). Cryoport had a negative return on equity of 13.35% and a negative net margin of 70.08%.March 5, 2025 | marketbeat.comCryoport sees FY25 revenue $240M-$250M, consensus $244.96MMarch 5, 2025 | markets.businessinsider.comRoth MKM Sticks to Their Buy Rating for CryoPort (CYRX)March 5, 2025 | markets.businessinsider.comCryoport, Inc. (CYRX) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | seekingalpha.comCryoport reports Q4 EPS (42c), consensus (31c)March 4, 2025 | markets.businessinsider.comCryoport Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 4, 2025 | prnewswire.comCryoport (CYRX) Expected to Announce Earnings on TuesdayCryoport (NASDAQ:CYRX) will be releasing earnings after the market closes on Tuesday, March 4. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=667358)February 25, 2025 | marketbeat.comCryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025February 18, 2025 | prnewswire.comCryoport, Inc. (NASDAQ:CYRX) Given Consensus Rating of "Moderate Buy" by AnalystsShares of Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven analysts that are currently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and four have given a buy rating tFebruary 16, 2025 | marketbeat.comShort Interest in Cryoport, Inc. (NASDAQ:CYRX) Declines By 5.5%Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) was the target of a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 2,080,000 shares, a decline of 5.5% from the December 31st total of 2,200,000 shares. Currently, 4.4% of the company's shares are short sold. Based on an average trading volume of 405,400 shares, the short-interest ratio is presently 5.1 days.February 2, 2025 | marketbeat.comCryoport (NASDAQ:CYRX) investors are sitting on a loss of 80% if they invested three years agoJanuary 29, 2025 | finance.yahoo.comSG Americas Securities LLC Buys 45,430 Shares of Cryoport, Inc. (NASDAQ:CYRX)SG Americas Securities LLC increased its stake in shares of Cryoport, Inc. (NASDAQ:CYRX - Free Report) by 44.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 146,789 shares of the company's stock afterJanuary 28, 2025 | marketbeat.comCryoport, Inc. (NASDAQ:CYRX) Receives Average Rating of "Moderate Buy" from BrokeragesShares of Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) have been assigned an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation and four have given a buy recoJanuary 22, 2025 | marketbeat.comCryoport Introduces The Cryoport Express Cryogenic HV3 Shipping SystemJanuary 21, 2025 | markets.businessinsider.com Remove Ads Get Cryoport News Delivered to You Automatically Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter. Email Address CYRX Media Mentions By Week CYRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYRX News Sentiment▼0.270.64▲Average Transportation News Sentiment CYRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYRX Articles This Week▼183▲CYRX Articles Average Week Remove Ads Get Cryoport News Delivered to You Automatically Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Calliditas Therapeutics AB (publ) News Today Evotec News Today Dyne Therapeutics News Today Ardelyx News Today Ocular Therapeutix News Today Aurinia Pharmaceuticals News Today Adaptive Biotechnologies News Today Iovance Biotherapeutics News Today 89bio News Today Syndax Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYRX) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryoport, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cryoport With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CYRX Stock Free CYRX Stock Alerts